These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14954373)

  • 21. [Sulfones action on Mitsuda-negative communicants; immunobiological interpretation of the positive effects].
    SOUZA CAMPOS N
    Int J Lepr; 1948; 16(2):301. PubMed ID: 18935254
    [No Abstract]   [Full Text] [Related]  

  • 22. Histopathological changes due to sulfone therapy.; observations of 449 leprosy cases.
    AZULAY RD
    Int J Lepr; 1952; 20(4:1):485-9. PubMed ID: 13044341
    [No Abstract]   [Full Text] [Related]  

  • 23. [Remote results of treatment of leprosy by the sulfone J-51; presentation of patients].
    BASSET A
    Bull Soc Pathol Exot Filiales; 1956; 49(4):593-4. PubMed ID: 13396502
    [No Abstract]   [Full Text] [Related]  

  • 24. [Blood sulfone levels and anti-leprosy action].
    FLOCH H
    Publ Inst Pasteur Guyane Fr Inini; 1955 Apr; 16(359):1-6. PubMed ID: 13275989
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mechanism of action of sulfones in leprosy. IX. Mechanism of action of thymol derivatives of sulfone (silver or non-silver salts) administered orally].
    FLOCH H; GELARD A
    Publ Inst Pasteur Guyane Fr Inini; 1955 Mar; 16(357):1-11. PubMed ID: 13249662
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of blood sulfone after administration of a preparation of solubilized DDS to leprosy patients].
    GEORGES A; LECHAT M
    Ann Soc Belg Med Trop (1920); 1956 Oct; 36(5):525-36. PubMed ID: 13403479
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experiments with chlorpromazine combined with diaminodiphenyl sulfone in leprosy therapy].
    FLOCH H
    Bull Soc Pathol Exot Filiales; 1955; 48(3):402-4. PubMed ID: 13304619
    [No Abstract]   [Full Text] [Related]  

  • 28. [Trial combined treatment of leprosy by the sulfone J-51 at the Leproserie Saint-Antoine de Harar].
    FERON J
    Bull Soc Pathol Exot Filiales; 1956; 49(4):591-2. PubMed ID: 13396501
    [No Abstract]   [Full Text] [Related]  

  • 29. Ocular and otorhinolaryngological leprosy before and since sulfone therapy.
    AMENDOLA F
    Int J Lepr; 1955; 23(3):280-3. PubMed ID: 13306358
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sulfone therapy of leprosy; fate of diaminodiphenylsulfone acetylsulfonamide administered orally; mode of action].
    FLOCH H; LECUILLER A; SUREAU P
    Bull Soc Pathol Exot Filiales; 1953; 46(2):270-6. PubMed ID: 13082372
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diamino-diphenyl-sulfone, dihydrostreptomycin and p-aminosalicylic acid in the treatment of lepromatous leprosy].
    GONZALEZ OCHOA A; MARTINEZ BAEZ M; LAVALLE AGUILAR P; CASTRO ESTRADA S
    Bol Oficina Sanit Panam; 1952 Oct; 33(4):306-29. PubMed ID: 12977879
    [No Abstract]   [Full Text] [Related]  

  • 32. [Histological and bacteriological changes in lepromatous leprosy after treatment with diamino-diphenyl-sulfone (sulfone mère)].
    NICOLAU SG; VULCAN P
    Arch Klin Exp Dermatol; 1958; 207(5):486-98. PubMed ID: 13595786
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mechanism of action of sulfones in leprosy. XI. Mechanism of action of intramuscular monoethyl sulfone].
    FLOCH H; FAURAN P; MAILLOUX M
    Publ Inst Pasteur Guyane Fr Inini; 1957 May; 18(424):1-12. PubMed ID: 13522261
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vitamin PP therapy in leprosy; sulfone intolerance and leprotic reactions].
    FLOCH H; HORTH R
    Bull Soc Pathol Exot Filiales; 1952; 45(2):161-6. PubMed ID: 14954349
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of sulfone therapy].
    MARIANO J; NETO A
    Arq Min Leprol; 1952 Oct; 12(4):294-302; English transl, 362-70. PubMed ID: 13093469
    [No Abstract]   [Full Text] [Related]  

  • 36. [Symposium on sulfone therapy].
    Arq Min Leprol; 1952 Oct; 12(4):316-52; English transl, 382-415. PubMed ID: 13093473
    [No Abstract]   [Full Text] [Related]  

  • 37. [Observations on sulfone therapy].
    COSTA HM
    Arq Min Leprol; 1952 Oct; 12(4):307-10; English transl, 374-7. PubMed ID: 13093471
    [No Abstract]   [Full Text] [Related]  

  • 38. [Symposium on sulfone therapy].
    ALONSO AM
    Arq Min Leprol; 1952 Oct; 12(4):303-7; English transl, 370-4. PubMed ID: 13093470
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of sulfone therapy].
    BECHELLI LM
    Arq Min Leprol; 1952 Oct; 12(4):286-94; English transl, 354-62. PubMed ID: 13093468
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical evaluation studies in lepromatous leprosy; third series: nicotinamide, and BCG vaccination as supplements to diaminodiphenyl sulfone (DDS).
    DOULL JA; RODRIGUEZ JN; DAVISON AR; TOLENTINO JG; FERNANDEZ JV
    Int J Lepr; 1958; 26(3):219-35. PubMed ID: 13640759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.